Biotech Values

[DewDiligence]

GIVN is evidently back on the block:

http://www.globes.co.il/serveen/globes/docview.asp?did=1000896749&fid=1725

Sources inform ''Globes'' that Given Imaging Ltd. has resumed talks, which might lead to the sale of the company, almost a year after calling them off [#msg-83427298].

The developer of the PillCam endoscopic capsule for diagnosis of bowel diseases has a market cap of $675 million, following a 21% rise in its share price since the beginning of the year. The asking price reportedly reflects a company value of $750-800 million, a 20% premium on the current market cap, and the intention is to close a deal by the end of the year. The sources said that three companies are interested in acquiring Given Imaging, two as strategic investors and the third as a financial investor.